Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease
The aim of the investigation was to study the prevalence, clinical and prognostic values of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease. Examination was performed on 90 patients with diabetic nephropathy (DN...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2009-08-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/1923 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839570190764867584 |
---|---|
author | O. A. Pavlenko T. A. Kolosovskaya O. F. Sibireva Ye. Yu. Khitrinskaya V. Yu. Grankina V. V. Kalyuzhin |
author_facet | O. A. Pavlenko T. A. Kolosovskaya O. F. Sibireva Ye. Yu. Khitrinskaya V. Yu. Grankina V. V. Kalyuzhin |
author_sort | O. A. Pavlenko |
collection | DOAJ |
description | The aim of the investigation was to study the prevalence, clinical and prognostic values of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease. Examination was performed on 90 patients with diabetic nephropathy (DN) and 180 patients with chronic glomerulonephritis (CG). In addition to complete clinical and instrumental examination accepted in specialised clinic, with the help of polymerase chain reaction diagnostics of polymorphism of the referred above genes (samples of genomic DNA were obtained from peripheral blood leukocytes) was conducted. It was found that the protrombogenic mutations under investigation which are detected in patients with DN and CG more often than in healthy subjects are associated with development of hypercoagulation syndrome and higher risk of renal failure. |
format | Article |
id | doaj-art-958e96e2a35243669ca2b47c21d7a84b |
institution | Matheson Library |
issn | 1682-0363 1819-3684 |
language | English |
publishDate | 2009-08-01 |
publisher | Siberian State Medical University (Tomsk) |
record_format | Article |
series | Бюллетень сибирской медицины |
spelling | doaj-art-958e96e2a35243669ca2b47c21d7a84b2025-08-04T16:45:30ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842009-08-0184(2)808510.20538/1682-0363-2009-4(2)-80-851416Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney diseaseO. A. Pavlenko0T. A. Kolosovskaya1O. F. Sibireva2Ye. Yu. Khitrinskaya3V. Yu. Grankina4V. V. Kalyuzhin5Сибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетThe aim of the investigation was to study the prevalence, clinical and prognostic values of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease. Examination was performed on 90 patients with diabetic nephropathy (DN) and 180 patients with chronic glomerulonephritis (CG). In addition to complete clinical and instrumental examination accepted in specialised clinic, with the help of polymerase chain reaction diagnostics of polymorphism of the referred above genes (samples of genomic DNA were obtained from peripheral blood leukocytes) was conducted. It was found that the protrombogenic mutations under investigation which are detected in patients with DN and CG more often than in healthy subjects are associated with development of hypercoagulation syndrome and higher risk of renal failure.https://bulletin.ssmu.ru/jour/article/view/1923diabetic nephropathychronic glomerulonephritisprotrombogenic genotypesprevalenceprognosis |
spellingShingle | O. A. Pavlenko T. A. Kolosovskaya O. F. Sibireva Ye. Yu. Khitrinskaya V. Yu. Grankina V. V. Kalyuzhin Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease Бюллетень сибирской медицины diabetic nephropathy chronic glomerulonephritis protrombogenic genotypes prevalence prognosis |
title | Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease |
title_full | Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease |
title_fullStr | Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease |
title_full_unstemmed | Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease |
title_short | Prevalence, clinical and prognostic value of polymorphism of genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease |
title_sort | prevalence clinical and prognostic value of polymorphism of genes ii v factors of blood coagulation and methylenetetrahydrofolate reductase in patients with chronic kidney disease |
topic | diabetic nephropathy chronic glomerulonephritis protrombogenic genotypes prevalence prognosis |
url | https://bulletin.ssmu.ru/jour/article/view/1923 |
work_keys_str_mv | AT oapavlenko prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease AT takolosovskaya prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease AT ofsibireva prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease AT yeyukhitrinskaya prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease AT vyugrankina prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease AT vvkalyuzhin prevalenceclinicalandprognosticvalueofpolymorphismofgenesiivfactorsofbloodcoagulationandmethylenetetrahydrofolatereductaseinpatientswithchronickidneydisease |